Company number: 02949804 Charity number: 1073453 Centre for Research and Implementation of Clinieal Practice (A company limited by guarantee) Directors, report and financial statements for the year ended 30 March 2024 •ADUE49&D* 1610112025 COMPANIES HOUSE A6
Centre for Research and Implementation of Clinical Practice (A compgny limited by guarantee) Contents Page Legal and administrative infomaiion Trustees, (directors) report Independent ¢xamin¢rfs report Staternent of financihl activities Balance sheet Notes to the financial slaternents 9-11
Centre for Research and Implementation of Clinical Practiee (A company limited by guarantee) Legal and administrative information Charity number 1073453 Company registration number 02949804 Registered offi¢e 7-8 Ritz Parade Western Avenue London W5 3RA Charity Trustees (directors) P J Franks C J Moffatt S G Murray J A Stirlin8 Secretary P J Franks Independent examiner Arvind Joshi FCA CTA DChA Levy + Partners Limited Chartered Accountants 7-8 Rilz Parade Western Avenue London W5 3RA Bankers Barclays Barth plc Fulham Broadway Branch Hammersmith Business Centre Group POBox738 London W6 9HY Page I
Centre for Research and Implementation of Clinical Practice (A company limited by guarantee) Trustees, Report (incorporating the directors, report) for the year ended 30 March 2024 The trustees, who are also directors of the charity for the purpose of the Companies Act 2006, present their report with the financial statements of the chariiable company for the year ended 30 March 2024. Principal activity and review The Centre for Research and Implementation of Clinical Practice (CIUCP) is a private company limited by guarantee and accordingly does not have a share capital. It was incorporated on 18 July 1994. The company was registered as a charity on 22 January 1999. Th¢ Charity is known informally as the Centre for Research (CRJCP). Slructure, governance And management The company's governing documenl is the Memorandum and Articles of A550ciation, as amended by a special resolution dated 22 November 2023. Objectives and activities The company's objectives and activilies are the evaluation and implementation of research based practice into the treatment of chronic wounds, including leg ulceration, pressure ulceration and lymphoedema, through research, education and audit. A¢hlevements and performance The company continues its work in lymphoedema and chronic wounds. The close partnership with the International Lymphoedema Framework (ILF) continue5 Wlth the work expanding to take in new countries. Our publication policy may change in that there is a possibility thal we will no longer be producing a third dedicated edition of Lynphali¢ Resear¢h & Biology, but this has yet lo be fJnalis¢d. The Limprint database continues to offer us opportunities for new research, and Child Limprint is progressing well. Financial review In the period under review the company returned a deficit on ordinary activities.. Deficit on ordinary activities Retained reserves brought forward (33,896) 34,449 Retained reserve5 caLed forward 553 Page 2
Centre for Research and Implementation of Clinical Practice (A company limited by guarantee) Trustees, Report (incorporating the directors, report) for the year ended 30 March 2024 Future developments The company's general income stream has become Challenging as Ihe regular income from our industy partners is no longer available. The company continues to offer support to health care providers and companies by developing research opportunities in the areas of wound care and lymphoedema. We continue to support AOTI in their work on venous leg ulceration and a new project on diabetic foot ulceration. Public benefit The trustees confirni that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's objectives and activities and in planning future activities. The work undertaken by CRICP relates to Ihe management of important health issues. To advance these areas, CRICP undertakes research wiih clinical partners lo develop patient orienlaled approaches lo describe th05e patients who suffer from these conditions. and to examine the polential benefils of the appropriate management according to their own health and quality of life, and the potential benefits to the health organisalions who manage them. 11 is the judgement of the trustees that activities in pursuit of the above objectives fijlly meei Ihe public benefit test, which they have kept in mind in planning programrnes for the charity. Statement of trustees, responslbllities The trustees, who are also the directors of Centre for Research and Implementation of Clinical Practice for the purpose of company law, are responsible for preparing Ihe Trustees, Report and Ihe accounts in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the trustees lo prepare fmancial statements for each fancial year. Under company law the trustees must not approv¢ the finan¢i81 stat¢m¢nts unless they are satisfied that they give 8 true and fair view of th¢ stale of affairs of the charitable company and of the incoming resources and application of resources, including the income and expendiiure of the charitable company for that period. In preparing these financial staiements, the Irusiees are required to.. select suitable a¢counting poli¢i¢s and ihen apply them consisiently* observe the methods and principles in the Charities SORP. make judgments and estimates Ihat are reasonable and prudent: slate whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the accounts. and prepare Ihe financial stal¢men15 on th¢ going concern basis unless it is inappropriate to presume that the charitable company will continue in business. The trustees are responsible for maintaining proper accounting records which disclos¢ with reasonable accuracy at any time the fanCIal position of the charilable company and to enable them to ensure that the accounts comply with the Companies Arl 2006. They are also r¢5ponsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The charity trustees who served during the year and up to the date of this report are set out on page l. Page 3
Centre for Research and Implementatlon of Cllnlcal PrHctlce (A company limlted by gllaraDtee) Trllstees, Report (tncDrporatin£ tho direetors, report) ror the year ended 30 March 2024 Auditors Under ¢lwtsvk rw)lulion dAtcd 16 T)ec¢mber 1994 it was r¢solvd to dibTr¢ThS¢ with th¢ obli¥81ion ¢0 appoinl auditors Dnually. Undcr thc provisions of the Companie5 AGt¥ u¥ th¢ company is a sm&ll cornpany audit is DO lon¥ requir. Mc8srs. T£vy & PArtners bave sigthfied their WAllitistiess (o aclgs iodependent examiners. This report pproved by the Board on 8 January 2025 #nd tsignp3J on ils beh[bY.. P J Franks Trustet (Director) Pgge 4
Centre for Research and Implementation of Clinical Practice (A company limited by guarantee) Independent examiner's report to the trustees of Centre for Research and Implementation of Clinical Practice. I report to the charity trustees on my examination of the account5 of Centre for Research and Implementation of Clinical Practice (a company limited by guarantee) for the year ended 30 March 2024, as sel out on pages 2 to I Responsibilities and basis of report As the charity's trustees (who are also the directors of the company for the purposes of company law), you are responsible for the preparation of the accounls in accordance with the requirements of the Companies Aci 2006 ("the 2006 Act"). Having satisfied myself ihal the accounts of the Company are not required to be audited for this year under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as Caled out under section 145 of the Charities Act 2011 ("the 201 l Act"). In carrying out my examination, I have followed the Directions given by the Charity Commission under section 145(5){b) of the 201 l Act. Independent examlner's statement I have completed my examinaiion. I confim that no material matters have com¢ to my attention which gives me Gause to believe that.. l accounting records were not kept in accordan¢¢ with section 3 86 of the Companies Act 2006; or 2 the accounts do not accord with such records. or 3 Ihe accounts do not comply with relevant ac¢ounting requirements under section 396 of the Companies Act 2006 other than any requirement that the accounts give a 'lrue and faiv view which is not a matter considered os part of an independent examination: or 4 the accounts have noi been prepared in accordance wilh the Charities SORTr (FRS102), I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Arvin i FCA CTA DChA Independent examiner Le*y + Partners Limited Chartered Accountants 7-8 Ritz Parade Western Avenue London W5 3RA Date.. 8 January 2025 Page 5
Centre for Research and Implementation of Clinical Practice (A company limited by guarantee) Statement of financial activities (incorporating the income and expenditure account) For the year ended 30 Mareh 2024 Unrestrlcted fund$ 2024 Total 2023 Total Notes Income Research Bank interest r¢c¢ived 35,694 360 35,694 360 65,500 187 Total income 36,054 36,054 65,687 Expenditure Research cosls Governance costs 33,580 36,370 33,580 36,370 44,714 45,513 Total expenditure 69,950 69,950 90,227 Net movement In funds (33,896) (33,896) (24,540) Total funds brought forward 34.449 34,449 58,989 Total funds carried forward 553 553 34,449 All of the above amounts relate to continuing activities. There are no restricted funds. There are no recognised gains or losses oiher than the surplus or deficit for the above two financial years. The notes on pages 9 to 11 form an integral parl of these financlal statements. Pag¢ 6
Centre for Research and Implementation of Clinical Praetiee (A company limited by guarantee) Balance sheet as at 30 March 2024 2024 2023 Notes Current assets Cash at bank and in hand 9,098 44,768 9,098 44,768 Creditors: amounts falling due within one year (8,545) (10,319) Net current assets 553 34,449 Net assets 553 34,449 Funds of the charity Unreslricied funds 553 34,449 Total charity funds 553 34,449 The Balance Sheet Continues on Ihe following page. The notes on pages 9 ¢0 11 form an integral part of these financial statements. Page 7
Centre for Research and TmplementatJoD of ClinlcAI Pracdce (A company Ilmited by guarantee) BalaDce sheet (eotttAtied) Trustees, (dlreetors) statements requiTed by the Companles Act 2006 for the year ended 30 March 2024 In rapproving these finunciul yÉdternL1ts a8 IruRteeR (di¢tors) of th¢ ¢haritubl¢ compaDy. h¢r¢by nfiM}. tltht for th¢ y¢af 8t&tcd abovc th¢ chBritsble compally was ell¢itlal lo thc txemption from an &udit under section 477 of the Companies Act 2006, The members have not Tequir¢d the ¢h&ritable compaoy to obiain an audit of its a¢wunts for the year in questioi) in acceldCe witb section 476 of the Act. The tru8teeFJdir¢ctOTS a&nOwled thir rcspvn¥ibilitie$ tor COLnplyin8 with thc rquironcnt¥ vf thc C,ompani&4 Acl 2006 with respect lo aoUtill8 rncords and prcpAratiDn of aceounL8. The finonci statements wLrb' 4Wpr0v by the board on 8 January 2025 and 8igtt¢d on its behalf by P J Franks Trustse (Dlreetor) Company nuntber.. U2949804 Th¢ notes on p8g¢$ 9 to 11 form integral part frf these fiuancial statements. Page 8
Centre for Research and Implementation of Clinical Practiee (A Company limited by guarantee) Notes to financial statements for the year ended 30 Mareh 2024 Statement of compliance The principal accounting policies are summarised below. The accounting policies have been applied consistently throughout th¢ year and (h¢ preceding y¢ar. Basis of accounting The financial statements have been prepared under the historical cost convention and in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities- Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective l January 2015), and the Companies Act 2006 as it applies from l January 2015. The charity is a Public Benefit Entity as defined by FRS 102. 1.2. Income All incoming resources are included in the statement of fLnancial acrivilies when the charity is entitled lo the income and the amount can be quanlified with reasonable accuracy. Income from investments is included in the year in which it is receivable. 1.3. Expenditure Exp¢nditrJre is recognised in the period in which the expenditure is incurred. Expenditure includes any VAT which cannot be fully recovered, and is reported as part of the expenditure to which it relates. Charitable expenditure comprises those costs incurred by the charitable company in the delivery of its activities and services for its beneficiaries. 11 includes both costs that can be allocated directly io such activities and those costs of an indire¢i narure ne¢essory to support ihem. Support cost5 are those costs incurred directly in support of expenditure on the objects of the charity and include project management. Research and development Research expenditure is written off to the surplus/(d¢fi¢it) account in the year in which it is incurred, Costs of charitable activities Unrestricted fund$ 2024 Total 2023 Total Wages & Salaries 33,580 33,580 44,714 33,580 33,580 44.714 Page 9
Centre for Research and Implementation of Clinical Practice (A company limited by guarantee) Notes to financial statements for the year ended 30 Mareh 2024 Governance costs Unrestrlcled funds 2024 Total 2023 Tolal Accountancy fees Insuranc¢ Professional Office costs General expenses Bank tharge5 Research & development costs 1,224 3,000 1.224 3,000 1,224 2,733 100 1,640 35 102 39,679 352 173 102 31,519 352 173 102 31,519 36,370 36,370 45,513 Employees Employment costs 2024 2023 Wages and salaries 33,580 44,714 No employee received emoluments of more than £60,000 (2023 None). Number of employees The average monThly numbers of employees (including the trustees) during the year, calculated on the basis of full time equivalents, was as follows: 2024 Iyumber 2023 Number Taxation The company is exempt from tax on its charitable activities as il is a registered charity. Page 10
Centre for Research and Implementation of Clinical Praetice (A company limited by guarantee) Notes to financial statements for the year ended 30 March 2024 Credltors: amounts falling due within one year 2024 2023 Other creditors Other taxes and social security Other creditors 7,156 21 .368 7.156 ,795 1,368 8,545 10,319 Unrestricted funds At At 31 March 2024 l April Incoming Outgoing 2023 resources resources Unrestricied Funds 34,449 36,054 (69,950) 553 Related party transactions Stuart Moffatt, the husband of Christine Moffatt (a director), provides financial services to the company. The charge for his services amounted io £lOO. Going concern The financial statemenls have been prepared on the assumption that the charitable company is able to carry on operations as a going concern, which th¢ directors consider appropriate having regard to the circumstances. 10. Company limited by guarantee Centre for Research and Implemenlalion of Clinical Practice is a company limited by guarantee and accordingly does not have a share capital. The directors as members of the company. undertake to contribute such amount as may b¢ required not exceeding £1 to the assets of the charitable company in th¢ ¢v¢nl of it5 being wound up while he or she is a member, or within one year after he or sh¢ ceases lo be a member. Pagell